Welcome Minimize

Mary Knoll Capital Partners provides investment banking and strategic advice to middle market companies requiring proven counsel in mergers and acquisitions, private equity transactions, and business recapitalization. 

We specialize in representing entrepreneurial companies.  Having acquired, sold or raised capital for over 100 growth companies in the $5 to $100 million range, we understand difficult and challenging situations of revenue concentration, cyclical profitability, capital constraints, and small size.   We focus our efforts on healthcare services, outsourcing, and reverse logistic businesses where we can add value. 

Experience, Creativity, and Unrelenting Commitment to our Clients.

 
Join our Newsletter Minimize
Please subscribe to our mailing list
First Name:  
Last Name:
E-Mail Address:
Choose your delivery:
Choose your mailing list:
Add to Mailing List
 
Client and Firm News Print   Minimize

Mary Knoll is pleased to represent Advantage Management Solutions, Inc, based in Langhorne, Pennsylvania.  AMS provides complete sales outsourcing, data management and software solutions to leading pharmaceutical and biotechnology clients. AMS solutions help clients consolidate, manage, and enhance internal and external sources of prescription and demographic data. More accurate data, coupled with the firm’s proprietary AlignPlus software, provides clients with data driven, product specific metrics on how to maximize return on their sales and marketing investments while reducing the cost of bringing new pharmaceutical products to market.

  Read More...

Mary Knoll has successfully represented Iod Incorporated in their acquisition of Secure Health, Incorporated.  Secure Health Incorporated is the market leading provider of Release of Information Services in the the Pacific Northwest.  With the addition of Secure Health, Iod now provides services in 44 states.  Secure Health is Iod's first acquisition since its recapitalization with JP Morgan and Chase Capital Coorporationin September 2007.  Iod is actively seeking additional consolidation opportunities.

 

  

Mary Knoll is pleased to announce that Littelfuse, Inc. (NASDAQ/NGS:LFUS) has completed the acquisition of Mary Knoll client Shock Block, Inc, and its K-Tec branded line of ground-fault protection products. The company, which operates a facility in Dallas, Texas, is a leading supplier of specialty high-current ground-fault protection devices for use in a wide variety of industrial applications.

  Read More...


 
M & A News Print   Minimize

Get Ready to Ride the New Competitive Consolidation Wave
Mergers and acquisitions are in the air.

M&A: Takeover Spree May Point to a Pickup
A spate of mergers and acquisitions during the past two weeks may signal the start of a comeback for global dealmaking in the second half of 2010

Mergers and acquisitions
Notable mergers and acquisitions in the Bay Area last week. Deal type{+1}Announced Acquirer Acquirer's cityTarget Target's citySeller Seller's cityTotal value{+2}StatusACQJuly 19Atheros Communications Inc.Santa ClaraOpulan Technologies Corp.$72PendingDIVJuly... Mergers and acquisitions - Business - San Francisco Bay Area - Business Services - Consulting

Sanofi CEO Targeting Everything but Blockbusters
Sanofi-Aventis CEO targeting emerging markets, consumer products _ everything but blockbusters Sanofi-Aventis - Genzyme - Mergers and acquisitions - Business - United States

Deals of the day -- mergers and acquisitions
(Adds Lufthansa, Zale Corp; updates Sanofi Aventis)

UPDATE 2-Deals of the day -- mergers and acquisitions
(Corrects to fix time in paragraph 1 to 2000 GMT)

Sanofi-Aventis CEO Viehbacher at a glance
SANOFI-AVENTIS SA CEO Christopher A. Viehbacher. AGE -- 50. Sanofi-Aventis - Genzyme - Business - Food and Drug Administration - Mergers & Acquisitions

Deals of the Day: Meet Li Lu Possible Buffett Successor
Deals of the Day gathers all the biggest news of the morning related to mergers and acquisitions, bankruptcies, financing and private equity.

Lessons from the End of the Charles River Deal
In the face of insurmountable shareholder opposition, Charles River Laboratories International has agreed to terminate its $1.6 billion proposed takeover of WuXi PharmaTech , a Chinese drug research and development outsourcing company.

Airlines living on the edge: CEO
Airlines talk business in billions but the difference between big profits or large losses is small, says Cathay Pacific Airways chief executive Tony Tyler.Airlines went through a desperately bad time during 2008 and 2009, with...